Painful oral aphthae and myositis

被引：1
|
作者：
Lorente-Lavirgen, Ana I. [1 ]
Pulpillo-Ruiz, Agueda [1 ]
Luque-Marquez, Rafael [2 ]
Cabrera-Perez, Rocio [3 ]
Conejo-Mir, Julian [1 ]
机构：
[1] Hosp Univ Virgen del Rocio, Dept Dermatol, Seville 41013, Spain
[2] Hosp Univ Virgen del Rocio, Dept Infect Dis Microbiol & Prevent Med, Seville 41013, Spain
[3] Hosp Univ Virgen del Rocio, Dept Pathol, Seville 41013, Spain
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2012年 / 51卷 / 10期
关键词：
FEBRILE NEUTROPHILIC DERMATOSIS; SWEETS-SYNDROME; MYELODYSPLASTIC SYNDROMES;
D O I：
10.1111/j.1365-4632.2011.05152.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1239 / 1241
页数：3
相关论文
共 50 条
  • [31] CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
    Garcia-Manero, Guillermo
    Scott, Bart L.
    Cogle, Christopher R.
    Boyd, Thomas E.
    Kambhampati, Suman
    Hetzer, Joel
    Dong, Qian
    Kumar, Keshava
    Ukrainskyj, Stacey M.
    Beach, C. L.
    Skikne, Barry S.
    LEUKEMIA RESEARCH, 2018, 72 : 79 - 85
  • [32] New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine
    Niscola, Pasquale
    Mazzone, Carla
    Molica, Matteo
    Fabritiis, Paolo de
    FUTURE ONCOLOGY, 2021, 17 (16) : 1973 - 1975
  • [33] SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia
    Nasnas, Patrice
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : 205 - 213
  • [34] Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Cogle, Christopher R.
    Scott, Bart L.
    Boyd, Thomas
    Garcia-Manero, Guillermo
    ONCOLOGIST, 2015, 20 (12): : 1404 - 1412
  • [35] Population Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia
    Gaudy, Allison
    Laille, Eric
    Bailey, Rochelle
    Zhou, Simon
    Skikne, Barry
    Beach, C. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 845 - 852
  • [36] Sweet Syndrome Induced by Oral Acetaminophen-Codeine Following Repair of a Facial Fracture
    Bradley, Laurence M.
    Higgins, Shauna P.
    Thomas, Monee M.
    Rodney, Ife J.
    Halder, Rebat M.
    CUTIS, 2017, 100 (03): : E20 - E23
  • [37] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH DAILY ORAL IDARUBICIN - A PHASE I-II STUDY
    GREENBERG, BR
    REYNOLDS, RD
    CHARRON, CB
    SQUILLACE, KM
    LESSIN, LS
    CASE, DC
    GAMS, RA
    CANCER, 1993, 71 (06) : 1989 - 1992
  • [38] Oral and intravenous pharmacokinetics of 5-fluoro-2′-deoxycytidine and THU in cynomolgus monkeys and humans
    Holleran, Julianne L.
    Beumer, Jan H.
    McCormick, David L.
    Johnson, William D.
    Newman, Edward M.
    Doroshow, James H.
    Kummar, Shivaani
    Covey, Joseph M.
    Davis, Myrtle
    Eiseman, Julie L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 803 - 811
  • [39] Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study
    Klein, CE
    Kastrissios, H
    Miller, AA
    Hollis, D
    Yu, DH
    Rosner, GL
    Grinblatt, DL
    Larson, RA
    Ratain, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 199 - 206
  • [40] Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients
    Niscola, Pasquale
    EXPERT REVIEW OF HEMATOLOGY, 2025,
12345